To make this website work, we log user data. By using Shephard's online services, you agree to our Privacy Policy, including cookie policy.

×
Open menu Search

Defiant protest grounds US Army FLRAA contract

4th January 2023 - 17:00 GMT | by Norbert Neumann in London

RSS

Bell Textron’s V-280 Valor won the US Army’s FLRAA competition in early December. (Photo: Bell Textron)

Boeing and Sikorsky think the US Army's decision on the Future Long-Range Assault Aircraft was not made in the right way and have filed a protest with the US Government Accountability Office, pausing the programme for more than three months.

The Lockheed Martin Sikorsky-Boeing Defiant X team closed 2022 with a highly anticipated move, challenging the US Army’s decision on the Future Long-Range Assault Aircraft (FLRAA) contract.

Bell Textron’s V-280 Valor won the FLRAA competition in early December, and the company was set to receive a contract worth up to $1.3 billion with the initial package estimated at $232 million over the next 19 months.

Team Defiant X, however, did not think the decision was made in the right way and filed a protest with the US Government Accountability Office (GAO).

In an official statement published on 28 December, the team

Already have an account? Log in

Want to keep reading this article?

Read this Article

Get access to this article with a Free Basic Account

  • Original curated content, daily across air, land and naval domains
  • 2 free stories per week
  • Daily news round-up email service
  • Access to all Decisive Edge email newsletters
Create account

Unlimited Access

Access to all our premium news as a Premium News 365 Member. Corporate subscriptions available.

  • Original curated content, daily across air, land and naval domains
  • 14-day free trial (cancel at any time)
  • Unlimited access to all published premium news
Start your free trial
Norbert Neumann

Author

Norbert Neumann


Norbert is the Aviation, Military Training & Simulation reporter at Shephard Media. Before joining Shephard in …

Read full bio

Share to

Linkedin